XTalks

JULY 15, 2024

Congenital HI is a genetic disorder that causes excessive insulin production by the pancreas, which lowers plasma or blood sugar. Agonist engagement of the receptor is involved in insulin and glucose regulation, and hence has therapeutic implications for diseases like diabetes and obesity.

Insulin 52

Insulin Drugs Life Science Marketing 52

XTalks

DECEMBER 13, 2024

Petrelintide, administered once a week under the skin, targets obesity through its action as an amylin analog, a hormone co-secreted with insulin from the pancreas. Amylin helps regulate satiety and slows gastric emptying, which can support weight loss.

Drugs 80

Drugs Hormones Trials Clinical Trials 80

XTalks

FEBRUARY 8, 2021

While there are currently six biosimilars for AbbVie’s Humira (adalimumab) that have been approved by the regulator, the company’s patents prevent biosimilars from being launched until 2023. The regulator allows biosimilars to show slight differences in clinically inactive components of a product.

Production 78

Production Insulin Branding Generic Drugs 78

XTalks

JUNE 10, 2024

Efruxifermin is a novel Fc-FGF21 fusion protein designed to emulate the activity of native FGF21, an endogenous hormone that regulates metabolism and alleviates cellular stress. It not only reduces liver fat and inflammation but can also reverse fibrosis, enhance insulin sensitivity and improve lipid profiles.

Insulin 52

Insulin Life Science Regulation Hormones 52

pharmaphorum

OCTOBER 2, 2020

Beyond this, there are other factors within the control of the healthcare and life sciences industries that will determine how ubiquitous self care actually becomes. The audit shows that product safety, efficacy and regulation are the primary drivers of trust in self-care. Self-care via TikTok.

Regulation 111

Regulation Doctors Doctor Production 111

XTalks

JANUARY 25, 2023

XTALKS WEBINAR: Review of Key Trends for Life Science Commercial Teams in 2023 Register for this free on-demand webinar to learn about the latest trends in sales and marketing campaigns that could help bolster commercial success for life science companies this year.

FDA Approval 52

FDA Approval Drugs Life Science Cosmetics 52

XTalks

FEBRUARY 6, 2024

Revita, an outpatient endoscopic procedural therapy, which aims to eliminate insulin needs and enhance glycemic control by ablating dysfunctional duodenal mucosa. Fractyl Health has initiated discussions with European regulators to establish an investigational new drug (IND)-enabling pathway for RJVA-001 in the treatment of T2D.

Gene Therapy 98

Gene Therapy Gene Clinical Trials Clinical Trials 98

XTalks

APRIL 29, 2022

Tirzepatide is a novel investigational obesity treatment that contains mimetics of two hormones that are involved in regulating appetite in a single peptide: a GIP (glucose-dependent insulinotropic polypeptide) receptor agonist and a GLP-1 (glucagon-like peptide-1) receptor agonist.

Trials 98

Trials Drugs FDA Approval Clinical Trials 98

XTalks

OCTOBER 11, 2023

They mimic the action of GLP-1, a hormone that helps regulate blood sugar levels by enhancing insulin secretion. GLP-1 agonists/inhibitors work by slowing digestion to suppress appetite but can cause problems if that process slows down too much.

Drugs 59

Drugs Insulin Hormones FDA Approval 59

XTalks

SEPTEMBER 17, 2020

Often, the potential patient pool for a given trial is small and the unmet need is high, incentivizing drugmakers and regulators to find innovative ways to make game-changing therapeutics available to those who need them most. Also known as Berardinelli-Seip syndrome, there are four subtypes of lipodystrophy.

Trials 98

Trials Gene Hormones Clinical Trials 98

XTalks

AUGUST 2, 2023

In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. It is a dipeptidyl peptidase-4 inhibitor that keeps insulin levels stable and reduces the amount of glucose produced by the body. Merck’s total global revenue from Lagevrio was $5.68

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

JUNE 12, 2023

Internationally, Medtronic expanded its MiniMed 780G insulin pump and Guardian 4 sensor. Significantly, Roche received full compliance under the In-Vitro Diagnostic Medical Devices Regulation (IVDR) from the European Union. It also plans to launch these products in the US.

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

XTalks

FEBRUARY 8, 2024

Diabetes remains a critical global challenge, affecting millions of lives and commanding significant attention from the medical, life sciences and pharmaceutical sectors. In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6 percent in the fourth quarter and decreased 56.7 from $289.36.

Sales 52

Sales Insulin FDA Approval Drugs 52

Pharma in Brief

AUGUST 9, 2021

On July 31, 2021, Health Canada published a Notice of Intent outlining its plan to amend the Food and Drug Regulations ( FDR ) and the Medical Devices Regulations in the spring of 2022. Health Canada is accepting comments on the Minister of Health’s proposal to amend the FDR and the Medical Devices Regulations until October 28, 2021.

Regulation 98

Regulation Drugs Manufacturing Production 98

XTalks

MAY 20, 2022

The injection is intended to regulate blood sugar, in conjunction with diet and exercise, in adults with type 2 diabetes. Life science industry data analytics company Evaluate Vantage predicts that Mounjaro could bring in $4.9 percent more than placebo when used in combination with a long-acting insulin.

Insulin 52

Insulin Life Science Drugs Sales 52

XTalks

JANUARY 24, 2024

This disparity can be attributed to various factors, including the lack of government regulation on drug prices and the complex web of negotiations between drug manufacturers, insurers and pharmacy benefit managers. Americans consistently pay more for prescription drugs than people in other developed countries.

Drugs 64

Drugs Medicine Insulin Packaging 64

XTalks

DECEMBER 3, 2024

From blockbuster drugs like Ozempic to foundational treatments like insulin, these therapies showcase the diverse strategies used by pharma companies to meet the needs of a rapidly growing market. Price of Insulin: Varies significantly by type and brand of insulin. The company is targeting revenue of $40.4 billion to $41.6

Sales 105

Sales Insulin FDA Approval Drugs 105